(PubMed) Kozlov AV, Gille L, Staniek K, Nohl H
Abstract Aims/hypothesis There is a growing need for markers that could help indicate the decline in beta cell function and recognise the need and efficacy of intervention in type 1 diabetes
Frequently Asked Questions Is compounded tirzepatide as safe and effective as Zepbound
Alzheimer's & Dementia Journals+2The Lancet+2 A meta-analysis pooling many clinical trials (though mostly for diabetes endpoints) suggested that GLP-1 RAs (versus placebo or other drugs) may reduce risk of dementia among diabetics
Judge it instead by your own markers (energy, waist, weight) over four to six weeks
With the exception of His1, the largest difference in the interaction of GLP-1 and exendin-4 occurred within the mid-region of the peptides where their sequences differ substantially (E 16 EAVRL 21 for exendin-4 vs G 22 QAAKE 27 for GLP-1)